IAM
WX

Integre Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Integre Asset Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-66,746
Closed -$2.88M – 180
2015
Q3 		$2.88M Sell
66,746
-159
-0.2% -$6.71K 0.69% 37
2015
Q2 		$2.83M Sell
66,905
-8,219
-11% -$347K 0.59% 42
2015
Q1 		$2.91M Sell
75,124
-54,114
-42% -$2.08M 0.58% 41
2014
Q4 		$4.35M Sell
129,238
-137
-0.1% -$4.84K 0.9% 33
2014
Q3 		$4.53M Buy
129,375
+1,324
+1% +$45.4K 0.96% 33
2014
Q2 		$4.21M Sell
128,051
-10,532
-8% -$360K 0.9% 36
2014
Q1 		$5.11M Sell
138,583
-61,590
-31% -$2.26M 1.12% 32
2013
Q4 		$7.68M Sell
200,173
-6,584
-3% -$208K 1.74% 25
2013
Q3 		$5.67M Sell
206,757
-18,869
-8% -$447K 1.46% 28
2013
Q2 		$4.74M Buy
+225,626
New +$4.41M 1.27% 29

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Integre Asset Management's WX Position: Q4 2015 in Review

Integre Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 66,746 shares — an estimated $2.88M sold.

Integre Asset Management first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $7.68M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Integre Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Integre Asset Management sold 66,746 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $2.88M.
  • Integre Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Integre Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $7.68M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Integre Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.